Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Ltd Company History
Lincoln Pharmaceuticals is in the business of manufacturing and trading of pharmaceutical products.
2005
Lincoln Pharmaceuticals secures export order from England, UK
2005
2006
Lincoln Pharma introduces Nozzled Liquid formulations
Lincoln Pharmaceuticals secures order from Republic Democratic of Congo
Lincoln Pharmaceuticals introduces Vivian Roll On in Novel Drug Delivery System
The Company has signed agreement with Russian firm M/s. Fortune Impex Ltd for marketing Company's manufactured products in Russia.
Company has splits its Face value of Shares from Rs 10 to Rs 2
2006
2007
Lincoln Pharmaceuticals recommends final Dividend @ 12%
2007
2008
Lincoln Pharmaceuticals recommends final Dividend @ 12%
2008
2009
Lincoln Pharmaceuticals has incorporated new Company namely M/s. Zullinc Healthcare Ltd as wholly owned subsidiary Company of Lincoln Pharmaceuticals Ltd.
Company has Consolidates its Face value of Shares from Rs 2 to Rs 10
2009
2010
Lincoln Pharmaceuticals Ltd. gains market share with technologically advanced Collagen Bio-tech products
2010
2011
Lincoln Pharmaceuticals wins patent for a Novel Nasal Drug delivery system introduces India's first Nasal Spray treatment for Vomiting.
Lincoln Pharmaceuticals Ltd. introduces India's first Long-Acting Paracetamol 'Pa-12' for Long term relief from Fever and Pain
Lincoln Pharmaceuticals Ltd launches Antimalarial drug 'ARH 1' developed with innovative dose optimization technology, for the first time in the world.
Lincoln Pharmaceuticals Ltd. launches Ayurvedic Product 'ISL Granules' to serve mother and child healthcare segment.
Lincoln Pharmaceuticals has acquired / purchased 62 Lacs equity shares of M/s. Lincoln Parenteral Ltd and by virtue of said acquisition / purchase of equity share, M/s. Lincoln Parenteral Ltd has become subsidiary Company
2011
2012
Lincoln Pharmaceuticals has recommended the payment of Dividend @ Rs. 0.60/- per equity share (6%) on face value of Rs. 10/- each
2012
2013
Lincoln Pharmaceuticals has recommended the payment of Dividend of Rs. 0.60 (@ 6%) per equity share of face value Rs. 10/- each.
2013
2014
"Lincoln Pharmaceuticals Ltd has launched an Ultramodern State of Art plant for Injectable".
Company has commended the payment of Dividend of Rs. 0.60/- per equity share (@ 6%) of face value of Rs. 10/- each of the Company.
2014
2015
The company has successfully launched a cough syrup called Namcold DX which contains Dextromethorphan Polistrirex.
2015
2016
"Lincoln Pharmaceuticals launches Vaginal Spray for "FIRST TIME IN INDIA".
2016
2020
Lincoln Pharma gets Gujarat food & drug regulator nod to manufacture COVID-19 drugs.
=The company has received approval from the state regulator to manufacture varied dosages of HCQ tablets and HCQ sulfate tablets among others at Khatraj plant.
2020
2021
The company eceived approval for the company's manufacturing facility from Australia's medicines and medical devices regulator.
2021
